Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial.
Session:
Meet the Trialists - EMANATE
Topic:
Atrial fibrillation (AF)
Event:
ESC Congress 2017
Congress Presentation
About the speaker
Professor Michael Ezekowitz
Thomas Jefferson University Hospital, Philadelphia (United States of America)
4
presentations
0
follower
Access the full session
About the event
ESC 365 is supported by
